Most Recent

image: Eyes on Cancer

Eyes on Cancer

By | April 1, 2012

Techniques for watching tumors do their thing

4 Comments

image: Live and In Color

Live and In Color

By | April 1, 2012

How to track RNA in living cells

2 Comments

image: Truth and Beauty

Truth and Beauty

By | April 1, 2012

With strong foundations in both art and science, Ahna Skop has been able to capture the marvel of—and mechanisms behind—cytokinesis.

4 Comments

image: Baldness Genes Discovered?

Baldness Genes Discovered?

By | March 26, 2012

Researchers say they've found key molecular clues to a problem that plagues 80 percent of men.

0 Comments

image: Debate over RNA Transcription

Debate over RNA Transcription

By | March 19, 2012

Researchers question earlier findings of a new mechanism for gene regulation.

2 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

Take a tour through the revolutionary menthod's past, present, and future.

8 Comments

image: Promoting Death

Promoting Death

By | March 1, 2012

Editor's choice in biochemistry

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham